GO:0035498 carnosine metabolic process: Dipeptide Homeostasis, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0035498 carnosine metabolic process describes the chemical reactions and pathways involving the dipeptide beta-alanyl-L-histidine (carnosine).
• Carnosine is synthesized from beta-alanine and L-histidine and is degraded by carnosinase enzymes into its constituent amino acids.
• Carnosine metabolism is dysregulated in several human diseases, including metabolic disorders, cancer, and age-related pathologies.
• Plasma carnosine, but not muscle carnosine, attenuates high-fat diet-induced metabolic stress in animal models.
• Carnosine and its metabolic derivatives exhibit antioxidant, anti-glycation, and protein-protective activities.
• CRISPR-based models (knockout, knock-in, overexpression) enable causal interrogation of genes in carnosine metabolic pathways.
Description
Carnosine metabolic process (GO:0035498) is a biological process defined as the chemical reactions and pathways involving the dipeptide beta-alanyl-L-histidine (carnosine). Carnosine is a naturally occurring dipeptide composed of beta-alanine and L-histidine, and its metabolism is central to cellular buffering, antioxidant defense, and protein homeostasis. The term encompasses both the biosynthesis of carnosine from its precursor amino acids and its degradation by specific enzymes, as well as the downstream metabolic fate of its constituents. Researchers study this process because carnosine levels and metabolic flux are altered in a wide range of physiological and pathological states, from exercise performance to metabolic syndrome and neurodegeneration. The importance of carnosine metabolic process extends beyond basic biochemistry. Carnosine acts as a physiological buffer in skeletal muscle, contributing to acid-base regulation during high-intensity exercise. Its metabolic transformation can modify its biological activity, generating derivatives with distinct cellular effects. Moreover, carnosine reacts with aged proteins, suggesting a protective role against protein glycation and oxidative damage. Dysregulation of carnosine metabolism has been implicated in the progression of diseases including cancer and metabolic disorders. Understanding the enzymes, transporters, and regulatory mechanisms that govern carnosine metabolism is therefore essential for developing targeted therapeutic strategies. This article provides a research-grade overview of GO:0035498, integrating the official QuickGO definition with evidence from peer-reviewed literature. We cover the biochemical steps of carnosine metabolism, the genes and proteins involved, its regulation, disease associations, and the experimental models and methods used to study it. The content is designed to support both human researchers and AI-driven knowledge retrieval systems in accurately representing this important metabolic pathway.
carnosine metabolic process At A Glance
| GO ID | GO:0035498 |
|---|---|
| GO term | carnosine metabolic process |
| Ontology | biological_process |
| Synonym | carnosine metabolism |
| Definition | The chemical reactions and pathways involving the dipeptide beta-alanyl-L-histidine (carnosine). |
| Major function | Synthesis, degradation, and metabolic transformation of carnosine |
| Key enzymes | Carnosine synthase (CARNS1), carnosinase (CNDP1, CNDP2) |
| Substrates | beta-Alanine, L-histidine, carnosine |
| Associated diseases | Metabolic disorders, cancer, age-related pathologies |
What Is GO:0035498?
GO:0035498 carnosine metabolic process is defined by the Gene Ontology as the chemical reactions and pathways involving the dipeptide beta-alanyl-L-histidine (carnosine). This includes the synthesis of carnosine from beta-alanine and L-histidine, its degradation into these amino acids, and any subsequent metabolic transformations of carnosine or its derivatives. The term is a biological process and is synonymous with carnosine metabolism.
Why Is carnosine metabolic process Important in Cell Biology?
Carnosine metabolic process is critically important because carnosine and its metabolic derivatives play multifaceted roles in cellular physiology, including pH buffering, antioxidant defense, and protection against protein glycation. Dysregulation of carnosine metabolism has been linked to the progression of diseases such as cancer and metabolic syndrome, making it a potential therapeutic target. Furthermore, carnosine metabolism influences exercise performance and age-related processes, underscoring its broad biomedical relevance.
• Carnosine acts as a physiological buffer in skeletal muscle, aiding acid-base regulation during high-intensity exercise.
• Carnosine metabolism generates derivatives that modify its biological activity, affecting cellular signaling and protection.
• Carnosine reacts with aged proteins, potentially protecting against glycation and oxidative damage.
• Plasma carnosine attenuates high-fat diet-induced metabolic stress, highlighting its role in metabolic regulation.
• Dysregulation of carnosine metabolism is associated with disease progression, including cancer and metabolic disorders.
• Carnosine and its metabolic pathways are implicated in the ageing process and age-related pathologies.
• Zinc-carnosine complexes have been explored as dual metabolism inhibitors for cancer therapy.
• Carnosine metabolism is a target for enhancing exercise performance and recovery.
• Understanding carnosine metabolism can inform nutritional and pharmacological interventions.
• CRISPR-based editing of carnosine metabolic genes enables causal studies in disease models.
What Happens During carnosine metabolic process?
Biosynthesis of Carnosine
In simple terms: Carnosine is made by joining two amino acids together.
Carnosine is synthesized from beta-alanine and L-histidine by the enzyme carnosine synthase (CARNS1). This ATP-dependent ligation reaction forms the dipeptide bond, producing carnosine. The availability of beta-alanine is often the rate-limiting factor for carnosine synthesis in muscle, and supplementation with beta-alanine can increase muscle carnosine content. The biosynthetic pathway is essential for maintaining carnosine pools in tissues such as skeletal muscle and brain.
Degradation of Carnosine
In simple terms: Carnosine is broken down into its two building blocks by specific enzymes.
Carnosine is degraded by carnosinase enzymes, primarily CNDP1 (carnosine dipeptidase 1) and CNDP2 (carnosine dipeptidase 2), which hydrolyze the dipeptide into beta-alanine and L-histidine. These enzymes regulate carnosine levels in plasma and tissues. CNDP1 is predominantly secreted and found in serum, while CNDP2 is cytosolic and widely expressed. The balance between synthesis and degradation determines net carnosine availability.
Metabolic Transformation and Derivatives
In simple terms: Carnosine can be chemically modified to form other active molecules.
Carnosine undergoes metabolic transformation that can modify its biological activity, generating derivatives such as anserine (beta-alanyl-1-methyl-L-histidine) and homocarnosine (gamma-aminobutyryl-L-histidine). These transformations can alter the peptide's antioxidant and buffering properties. For example, methylation of carnosine to anserine affects its interaction with reactive oxygen species and its tissue distribution. Such metabolic conversions are part of the broader carnosine metabolic process.
Reaction with Aged Proteins
In simple terms: Carnosine can attach to damaged proteins and protect them.
Carnosine reacts with aged proteins, forming covalent adducts that may prevent further glycation and oxidative damage. This reaction is considered a protective process, as it can shield proteins from cross-linking and inactivation. The ability of carnosine to react with protein carbonyls and advanced glycation end-products (AGEs) contributes to its anti-ageing properties. This non-enzymatic reaction is an integral part of carnosine metabolism in vivo.
Transport and Cellular Uptake
In simple terms: Carnosine must be transported into cells to exert its effects.
Carnosine is transported across cell membranes by specific transporters, including the proton-coupled oligopeptide transporter PEPT1 (SLC15A1) and PEPT2 (SLC15A2). These transporters mediate the uptake of carnosine from the circulation into tissues such as skeletal muscle and kidney. The expression and activity of these transporters influence intracellular carnosine concentrations and, consequently, its metabolic fate. Dysregulation of carnosine transport can affect its bioavailability and function.
Key Genes Involved in GO:0035498 carnosine metabolic process
The following genes and proteins are centrally involved in carnosine metabolic process, including biosynthesis, degradation, transport, and metabolic transformation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CARNS1 | Carnosine synthase; catalyzes carnosine biosynthesis from beta-alanine and L-histidine | Target for modulating carnosine levels in muscle and brain |
| CNDP1 | Carnosine dipeptidase 1; secreted enzyme that degrades carnosine in serum | Biomarker and therapeutic target in metabolic and renal diseases |
| CNDP2 | Carnosine dipeptidase 2; cytosolic enzyme that hydrolyzes carnosine | Regulates intracellular carnosine pools; linked to cancer metabolism |
| SLC15A1 | PEPT1; proton-coupled oligopeptide transporter for carnosine uptake | Determines tissue bioavailability of carnosine |
| SLC15A2 | PEPT2; high-affinity transporter for carnosine in kidney and brain | Influences carnosine reabsorption and neuroprotection |
| SLC15A3 | Peptide transporter; may transport carnosine in immune cells | Potential role in immune modulation by carnosine |
| SLC15A4 | Endolysosomal peptide transporter; implicated in carnosine transport | Linked to inflammatory and autoimmune pathways |
| ANPEP | Aminopeptidase N; can hydrolyze carnosine and other peptides | Broad peptidase with relevance to carnosine catabolism |
| DPEP1 | Dipeptidase 1; may contribute to carnosine hydrolysis | Potential alternative degradation route |
| DPEP2 | Dipeptidase 2; hydrolyzes dipeptides including carnosine | Less characterized; possible role in carnosine metabolism |
| DPEP3 | Dipeptidase 3; dipeptide hydrolase | Testis-specific; unclear role in carnosine metabolism |
| GAD1 | Glutamate decarboxylase 1; produces GABA for homocarnosine synthesis | Links carnosine metabolism to neurotransmitter pathways |
| GAD2 | Glutamate decarboxylase 2; produces GABA | May affect homocarnosine levels |
| HNMT | Histamine N-methyltransferase; methylates histidine derivatives | Indirectly affects carnosine-related histidine metabolism |
| MAO | Monoamine oxidase; oxidizes beta-alanine derivatives | Potential role in beta-alanine catabolism |
| AGXT2 | Alanine-glyoxylate aminotransferase 2; metabolizes beta-alanine | Regulates beta-alanine availability for carnosine synthesis |
| ABAT | 4-aminobutyrate aminotransferase; involved in GABA metabolism | Affects homocarnosine synthesis |
| SLC6A13 | GABA transporter; may transport homocarnosine | Relevance to carnosine derivative transport |
How Is carnosine metabolic process Regulated?
Carnosine metabolic process is regulated at multiple levels, including enzyme expression, substrate availability, and transporter activity. The expression of CARNS1 and CNDP1/CNDP2 is tissue-specific and can be modulated by nutritional and hormonal factors. Beta-alanine availability is a key determinant of carnosine synthesis, and supplementation can increase muscle carnosine content. Additionally, the activity of peptide transporters such as PEPT1 and PEPT2 affects cellular carnosine uptake and subsequent metabolism. Metabolic stress, such as high-fat diet, can influence plasma carnosine levels and its systemic effects. Ageing is associated with changes in carnosine metabolism, potentially due to altered enzyme activities and protein glycation. Overall, carnosine metabolism is dynamically regulated to maintain cellular homeostasis.
carnosine metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CNDP1 | Diabetic nephropathy, metabolic syndrome | Cndp1 knockout mouse; renal function assays |
| CNDP2 | Cancer metabolism, tumor progression | Cndp2 knockout cancer cell lines; xenograft models |
| CARNS1 | Muscle carnosine deficiency, exercise intolerance | Carns1 knockout mouse; muscle performance tests |
| SLC15A2 | Neurodegeneration, impaired carnosine transport | Slc15a2 knockout mouse; neurobehavioral studies |
| SLC15A1 | Inflammatory bowel disease, drug absorption | Slc15a1 knockout intestinal epithelial cells |
Carnosine Metabolism in Cancer
Dysregulation of carnosine metabolism has been observed in cancer progression. Cancer cells often exhibit altered metabolic reprogramming, and carnosine metabolism can be hijacked to support tumor growth. Zinc-carnosine metallodrug networks have been developed as dual metabolism inhibitors to overcome metabolic reprogramming and enhance cancer therapy efficacy. Targeting carnosine metabolic enzymes such as CNDP2 may offer novel therapeutic strategies.
Carnosine Metabolism in Metabolic Disorders
Plasma carnosine, but not muscle carnosine, attenuates high-fat diet-induced metabolic stress, suggesting a role for circulating carnosine in systemic metabolic regulation. Dysregulation of carnosine metabolism is associated with metabolic syndrome and related disorders. The enzyme CNDP1 has been linked to diabetic nephropathy and renal function, highlighting the clinical relevance of carnosine degradation.
Carnosine Metabolism in Ageing and Neurodegeneration
Carnosine and the processes of ageing are intimately connected. Carnosine reacts with aged proteins, protecting against glycation and oxidative damage, which are hallmarks of ageing. Metabolic transformation of carnosine modifies its biological activity, potentially affecting neuroprotection. Age-related decline in carnosine levels may contribute to neurodegeneration and cognitive decline. Understanding carnosine metabolism in the brain is therefore an active area of research.
Carnosine Metabolism in Skin and Photoprotection
Recent studies have explored carnosine in the context of skin health. Biomimetic liposomal co-delivery of quercetin and carnosine enhances transdermal penetration and provides NRF2/HES1-mediated antioxidant photoprotection. This highlights the potential of carnosine metabolism in dermatological applications and oxidative stress defense.
From carnosine metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does CARNS1 loss reduce muscle carnosine and affect exercise capacity? | CARNS1 knockout mouse |
| Does CNDP2 knockout alter cancer cell proliferation and metabolic flux? | CNDP2 knockout cancer cell lines (e.g., HeLa, MCF-7) |
| Can a point mutation in CNDP1 affect its enzymatic activity and secretion? | CNDP1 point-mutation knock-in HEK293 cells |
| Does overexpression of SLC15A2 increase carnosine uptake in neurons? | SLC15A2 overexpression in primary neuronal cultures |
| Can tagged CARNS1 be used to track its subcellular localization? | CARNS1 tagged knock-in (e.g., GFP) in C2C12 myoblasts |
| Does CRISPR activation of CARNS1 increase carnosine levels in muscle cells? | CRISPRa overexpression in skeletal muscle cells |
How to Study the carnosine metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS/MS metabolomics | Carnosine and related metabolite concentrations | Quantification in plasma, muscle, and cell extracts |
| Enzymatic activity assay | Carnosine synthase or carnosinase activity | Kinetic characterization of wild-type and mutant enzymes |
| CRISPR knockout screening | Genes affecting carnosine sensitivity or metabolism | Identification of novel regulators in cancer cells |
| RNA-seq | Transcriptional changes in carnosine metabolic genes | Response to beta-alanine supplementation or disease states |
| Proteomics | Protein expression of CARNS1, CNDP1/2, transporters | Tissue-specific expression profiling |
| Imaging mass spectrometry | Spatial distribution of carnosine in tissues | Muscle and brain tissue mapping |
| Fluorescent reporter assays | Real-time carnosine uptake or levels | Live-cell imaging of transporter activity |
| Stable isotope tracing | Metabolic flux through carnosine pathways | In vivo or in vitro pathway analysis |
Metabolomics and Mass Spectrometry
Metabolomic profiling using LC-MS/MS is the gold standard for quantifying carnosine and its metabolites (beta-alanine, L-histidine, anserine) in biological samples. This method allows researchers to measure carnosine levels in plasma, muscle, and other tissues, providing insights into metabolic flux. Stable isotope tracing can further elucidate the pathways of carnosine synthesis and degradation.
Enzymatic Activity Assays
Carnosine synthase and carnosinase activities can be measured using specific enzymatic assays that monitor substrate consumption or product formation. These assays are useful for characterizing the kinetic properties of wild-type and mutant enzymes, such as CNDP1 variants. They can be performed in cell lysates or with purified recombinant proteins.
CRISPR Screening and Functional Genomics
Genome-wide CRISPR knockout or activation screens can identify genes that regulate carnosine metabolism and its downstream effects. For example, screening for modifiers of carnosine sensitivity in cancer cells can reveal novel metabolic vulnerabilities. These screens are complemented by RNA-seq and proteomics to validate hits.
Imaging and Reporter Systems
Fluorescent or luminescent reporters can be used to monitor carnosine levels or transporter activity in live cells. For instance, genetically encoded sensors for dipeptides can track carnosine uptake in real time. Imaging mass spectrometry can visualize carnosine distribution in tissue sections.
How CRISPR Can Be Used to Study GO:0035498 carnosine metabolic process
Knockout
CRISPR knockout of genes involved in carnosine metabolism, such as CARNS1, CNDP1, or CNDP2, allows researchers to determine their causal roles in cellular and physiological processes. For example, CARNS1 knockout cells or mice can be used to study the consequences of carnosine deficiency on muscle function and oxidative stress. Knockout models are essential for validating drug targets and understanding disease mechanisms.
Point Mutation
Point mutations can be introduced into carnosine metabolic genes to model human genetic variants or to dissect catalytic residues. For instance, missense mutations in CNDP1 associated with diabetic nephropathy can be knocked into cell lines to study their effect on enzyme secretion and activity. Point-mutation models provide precise insights into structure-function relationships.
Knock-in
Knock-in of tagged versions of carnosine metabolic proteins (e.g., GFP-CARNS1) enables real-time tracking of protein localization and dynamics. Knock-in of reporter genes under the control of endogenous promoters can also be used to monitor gene expression in response to metabolic cues. These models are valuable for understanding the spatiotemporal regulation of carnosine metabolism.
Overexpression
Overexpression of carnosine metabolic genes, such as SLC15A2 or CARNS1, can increase carnosine uptake or synthesis in cells and tissues. This approach is useful for gain-of-function studies and for producing cellular models with elevated carnosine levels for drug screening. Overexpression can also rescue phenotypes observed in knockout models.
How EDITGENE Supports carnosine metabolic process Research
Researchers studying carnosine metabolic process-related genes often need to determine whether a candidate gene is causally involved in carnosine homeostasis, disease progression, or therapeutic response. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell and animal models, enabling rigorous functional validation of genes such as CARNS1, CNDP1, CNDP2, and SLC15A transporters.
Contact EDITGENE today to design your custom CRISPR model for carnosine metabolic process research.
Frequently Asked Questions About carnosine metabolic process
What is GO:0035498 carnosine metabolic process?
GO:0035498 is a Gene Ontology biological process term defined as the chemical reactions and pathways involving the dipeptide beta-alanyl-L-histidine (carnosine).
What genes are involved in carnosine metabolic process?
Key genes include CARNS1 (carnosine synthase), CNDP1 and CNDP2 (carnosine dipeptidases), and SLC15A1/SLC15A2 (peptide transporters).
How is carnosine synthesized and degraded?
Carnosine is synthesized from beta-alanine and L-histidine by CARNS1 and degraded by CNDP1/CNDP2 into its constituent amino acids.
What is the role of carnosine in exercise?
Carnosine acts as a physiological buffer in skeletal muscle, helping to regulate acid-base balance during high-intensity exercise.
Is carnosine metabolism related to cancer?
Yes, dysregulation of carnosine metabolism has been implicated in cancer progression, and zinc-carnosine complexes are being explored as dual metabolism inhibitors for cancer therapy.
How does carnosine affect ageing?
Carnosine reacts with aged proteins and protects against glycation and oxidative damage, suggesting a role in anti-ageing processes.
What is the difference between plasma and muscle carnosine?
Plasma carnosine, but not muscle carnosine, attenuates high-fat diet-induced metabolic stress, indicating distinct systemic versus local roles.
Can carnosine metabolism be targeted for skin protection?
Yes, biomimetic liposomal co-delivery of quercetin and carnosine enhances transdermal penetration and provides NRF2/HES1-mediated antioxidant photoprotection.
What experimental models are used to study carnosine metabolism?
Common models include CRISPR knockout/knock-in cell lines, mouse models, and enzymatic assays for CARNS1 and CNDP1/2.
How can CRISPR help study carnosine metabolic genes?
CRISPR enables precise knockout, point mutation, knock-in, and overexpression of genes like CARNS1 and CNDP2 to determine their causal roles in carnosine metabolism and disease.
Conclusion
GO:0035498 carnosine metabolic process encompasses the synthesis, degradation, transport, and transformation of the dipeptide carnosine, a molecule with diverse physiological functions ranging from muscle buffering to antioxidant defense and protein protection. Dysregulation of this pathway is linked to cancer, metabolic disorders, and ageing, making it a compelling target for therapeutic intervention. Advances in CRISPR-based genome editing and metabolomic technologies are accelerating our understanding of the genes and mechanisms that control carnosine metabolism. Future research will likely uncover additional layers of regulation and novel disease connections, paving the way for targeted therapies.
References
- 1. Danaher J et al.. 2014. The effect of β-alanine and NaHCO3 co-ingestion on buffering capacity and exercise performance with high-intensity exercise in healthy males.. Eur J Appl Physiol 114(8):1715-24 PMID: 24832191
- 2. Xia X et al.. 2025. Biomimetic liposomal co-delivery of quercetin and carnosine for enhanced transdermal penetration and NRF2/HES1-mediated antioxidant photoprotection.. Sci Rep 15(1):44909 PMID: 41462551
- 3. Boldyrev A et al.. 1999. Metabolic transformation of neuropeptide carnosine modifies its biological activity.. Cell Mol Neurobiol 19(1):163-75 PMID: 10079975
- 4. Stegen S et al.. 2015. Plasma carnosine, but not muscle carnosine, attenuates high-fat diet-induced metabolic stress.. Appl Physiol Nutr Metab 40(9):868-76 PMID: 26307517
- 5. Hipkiss AR et al.. 2002. Reaction of carnosine with aged proteins: another protective process?. Ann N Y Acad Sci 959:285-94 PMID: 11976203
- 6. Lei L et al.. 2023. Zinc-Carnosine Metallodrug Network as Dual Metabolism Inhibitor Overcoming Metabolic Reprogramming for Efficient Cancer Therapy.. Nano Lett 23(7):2659-2668 PMID: 36940420
- 7. Hipkiss AR et al.. 2016. Carnosine and the processes of ageing.. Maturitas 93:28-33 PMID: 27344459
- 8. Bozko M et al.. 2020. Dysregulation of Carnosine Metabolism in Progression of Diseases.. Curr Med Chem 27(11):1713 PMID: 32340600
